Medicines Co. Gains After FDA Staff Recommends Anticlotting Drug

April 13, 2015 7:07 PM

2 0

Medicines Co. jumped the most in almost a month after Food and Drug Administration staff recommended the company’s intravenous blood clotting drug for approval.

The stock rose as much as 6.6 percent following an FDA staff report released Monday that said Kengreal should be approved for patients undergoing procedures to open blocked arteries.

Also read: BAT heaps $47 bln of peer pressure on Reynolds

Read more

To category page